A novel method for determining the inhibitory potential of anti-HIV drugs.
about
Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approachMathematical modeling of herpes simplex virus-2 suppression with pritelivir predicts trial outcomes.The A128T Resistance Mutation Reveals Aberrant Protein Multimerization as the Primary Mechanism of Action of Allosteric HIV-1 Integrase InhibitorsMultimode, Cooperative Mechanism of Action of Allosteric HIV-1 Integrase InhibitorsThe Antiviral Activity of Approved and Novel Drugs against HIV-1 Mutations Evaluated under the Consideration of Dose-Response Curve SlopeEvolutionary dynamics of HIV at multiple spatial and temporal scales.HRP2 determines the efficiency and specificity of HIV-1 integration in LEDGF/p75 knockout cells but does not contribute to the antiviral activity of a potent LEDGF/p75-binding site integrase inhibitor.Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris LDose-response curve slope helps predict therapeutic potency and breadth of HIV broadly neutralizing antibodiesRapid viral expansion and short drug half-life explain the incomplete effectiveness of current herpes simplex virus 2-directed antiviral agents.Multimodal mechanism of action of allosteric HIV-1 integrase inhibitors.Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.Combination antiretroviral therapy and cell-cell spread of wild-type and drug-resistant human immunodeficiency virus-1.Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection.Roles of Capsid-Interacting Host Factors in Multimodal Inhibition of HIV-1 by PF74.Instantaneous inhibitory potential is similar to inhibitory quotient at predicting HIV-1 response to antiretroviral therapy.A mechanistic theory to explain the efficacy of antiretroviral therapy.Pharmacokinetics and pharmacodynamics of atazanavir-containing antiretroviral regimens, with or without ritonavir, in patients who are HIV-positive and treatment-naïve.Mathematical modeling of viral infection dynamics in spherical organs.Quantifying the activity of anti-HIV treatment in silico
P2860
Q27324340-0925521B-72D9-4F5B-B241-053D2DF4EE73Q27324453-B07A7AB9-9B8A-4AFF-B80C-DEFFBD0DE5A5Q27677549-195E1CD6-C92D-4719-B436-E7ED8CE4A19FQ27678141-9AC7F20B-5E00-4DE1-9F87-1225FD893138Q28550441-143B38F4-E1B1-483D-9C2B-A73BF2F8E10BQ30416280-25028C7B-7298-491C-9481-66187466CD4DQ30459386-D605FA71-5097-49D5-BD08-CF5B6A205437Q34988956-337AAAED-516A-483E-B4CF-99B2352AA02FQ36105672-BC6C2A57-B938-4BB9-A15C-224A9355760FQ37335794-95605A14-5FA5-4949-8A0E-FB3D599C5389Q37574479-1F27DE7C-89D9-49A4-B34D-0DF94462FDBFQ37835819-CE287951-B15E-489B-A243-C100C2A33199Q38718627-E9363A3E-10C6-4DD4-8E55-A0D8768C68F7Q40341184-CD554367-F1A4-4D7A-88EA-85BC9B018DACQ40715418-2B82B581-CF84-461E-8F85-9617202BFA68Q40880324-44C5BDCD-01C9-43FA-81C9-A3CE173D7BBDQ43721565-6A03F2D4-AAF2-4A64-AA13-DE9D2EE0C7CEQ46825226-900E9EC2-EC6C-4151-A909-1C24E19E93FCQ51318158-D6DCD9A3-9BAD-4DD1-8C28-94A5B169A1A4Q56962315-C256DBB4-D4EB-4490-B2D9-6024BCFE54DF
P2860
A novel method for determining the inhibitory potential of anti-HIV drugs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A novel method for determining the inhibitory potential of anti-HIV drugs.
@en
A novel method for determining the inhibitory potential of anti-HIV drugs.
@nl
type
label
A novel method for determining the inhibitory potential of anti-HIV drugs.
@en
A novel method for determining the inhibitory potential of anti-HIV drugs.
@nl
prefLabel
A novel method for determining the inhibitory potential of anti-HIV drugs.
@en
A novel method for determining the inhibitory potential of anti-HIV drugs.
@nl
P2860
P1476
A novel method for determining the inhibitory potential of anti-HIV drugs.
@en
P2093
S Alireza Rabi
P2860
P304
P356
10.1016/J.TIPS.2009.09.003
P577
2009-12-01T00:00:00Z